全文获取类型
收费全文 | 520983篇 |
免费 | 36024篇 |
国内免费 | 11131篇 |
专业分类
耳鼻咽喉 | 6378篇 |
儿科学 | 10161篇 |
妇产科学 | 12572篇 |
基础医学 | 70257篇 |
口腔科学 | 14342篇 |
临床医学 | 47949篇 |
内科学 | 101833篇 |
皮肤病学 | 10209篇 |
神经病学 | 35771篇 |
特种医学 | 18859篇 |
外国民族医学 | 154篇 |
外科学 | 75889篇 |
综合类 | 29429篇 |
现状与发展 | 25篇 |
一般理论 | 73篇 |
预防医学 | 26376篇 |
眼科学 | 13446篇 |
药学 | 45174篇 |
116篇 | |
中国医学 | 8336篇 |
肿瘤学 | 40789篇 |
出版年
2022年 | 5960篇 |
2021年 | 8708篇 |
2020年 | 5967篇 |
2019年 | 6935篇 |
2018年 | 8855篇 |
2017年 | 7309篇 |
2016年 | 7145篇 |
2015年 | 9445篇 |
2014年 | 12479篇 |
2013年 | 13967篇 |
2012年 | 19555篇 |
2011年 | 20635篇 |
2010年 | 12556篇 |
2009年 | 10926篇 |
2008年 | 16612篇 |
2007年 | 17539篇 |
2006年 | 17396篇 |
2005年 | 16372篇 |
2004年 | 13800篇 |
2003年 | 13250篇 |
2002年 | 12200篇 |
2001年 | 32264篇 |
2000年 | 32945篇 |
1999年 | 27910篇 |
1998年 | 7678篇 |
1997年 | 6602篇 |
1996年 | 5602篇 |
1995年 | 5117篇 |
1994年 | 4519篇 |
1993年 | 3805篇 |
1992年 | 17759篇 |
1991年 | 16283篇 |
1990年 | 15454篇 |
1989年 | 15207篇 |
1988年 | 13662篇 |
1987年 | 13008篇 |
1986年 | 11880篇 |
1985年 | 11071篇 |
1984年 | 7373篇 |
1983年 | 5953篇 |
1982年 | 2929篇 |
1979年 | 5731篇 |
1978年 | 3477篇 |
1977年 | 3088篇 |
1975年 | 2759篇 |
1974年 | 3197篇 |
1973年 | 2990篇 |
1972年 | 2934篇 |
1971年 | 2883篇 |
1969年 | 2613篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
经尿道前列腺电切术后膀胱颈挛缩多因素分析 总被引:24,自引:2,他引:22
目的 :对经尿道前列腺电切术 (TURP)后膀胱颈挛缩 (BNC)发生的各种可能因素进行分析 ,探讨减少该并发症的途径。 方法 :对 10 17例行TURP患者中发生BNC的 2 4例进行统计学分析 ,在手术方法、前列腺电切重量、单位时间前列腺组织电切重量、置管时间、高频发生器类型及有无糖尿病、尿潴留及前列腺炎等方面进行比较 ,了解其可能发生的因素。 结果 :TURP术后BNC发生率明显高于开放手术病例 ,小前列腺、单位电切时间长、高频发生器功率大及术前前列腺炎患者易发生BNC(P <0 .0 5 ) ,而术前尿潴留、糖尿病及术后置管时间对BNC发生无明显影响 (P >0 .0 5 )。 结论 :小前列腺、前列腺炎及电流损伤是发生BNC的重要因素 ,患者的选择及熟练精确的电切技术可减少BNC的发生。 相似文献
992.
三维适形放射治疗局部复发鼻咽癌疗效观察 总被引:11,自引:2,他引:9
目的:观察三维适形放疗治疗局部复发鼻咽癌的近期疗效及放射损伤的发生率。方法:对42例局部复发鼻咽癌病例采用三维统计计划系统放射治疗计划,以剂量体积直方图评价和优化放射治疗计划,头部固定装置及多叶光栅技术实施适形放射治疗。计划靶区为临床所见肿瘤区外放7-10mm,计划靶区体积(PTV)中位体积为47.6cm^2(27.9-61.8cm^3),时间-剂量-分次采用:(5-5.5周)-(60-70Gy)-(24-28次),结果:三维适形放疗后,肿瘤局部控制率85.7%(36/42),2年生存率73.8%(31/42),放射损伤包括听力丧失7.1(3/42),张口困难35.7%(15/42),吞咽困难7.1%(3/42),慢性副鼻窦炎28.6%(12/42),脑神经损伤21.4%(9/42),结论:三维适形放疗治疗鼻咽放疗后鼻咽部局部复发有较好的近期疗效,而放射损伤较低,远期疗效尚待进一步观察。 相似文献
993.
994.
H. Kitamura T. Shioiri M. Itoh Y. Sato K. Shichiri & T. Someya 《Journal of intellectual disability research : JIDR》2007,51(10):812-820
Background Evidence suggests that, as a group, patients with schizophrenia have intellectual deficits that may precede the manifestation of psychotic symptoms; however, how successfully intelligence tests are able to discriminate schizophrenia from other psychotic disorders has yet to be investigated in detail. Methods Using Wechsler Adult Intelligence Scale – Revised (WAIS‐R) data for 55 inpatients with schizophrenia and 28 inpatients with non‐schizophrenic psychotic disorders (NSPD) (schizophreniform disorder, brief psychotic disorder, delusional disorder, psychotic disorder due to a general medical condition, and psychotic disorders not otherwise specified), intelligence performance was compared between schizophrenia and NSPD and among different subtypes of schizophrenia. Results There were no significant differences in intelligence quotient (IQ), verbal IQ (VIQ) and performance IQ (PIQ) discrepancy, and subtest scores of WAIS‐R between the patients with schizophrenia and those with NSPD. These diagnostic groups were not discriminated well by any WAIS‐R variables. Schizophrenia patients with prominent negative symptoms, on the other hand, had a significantly larger IQ discrepancy (VIQ > PIQ) than those without prominent negative symptoms and NSPD patients. Intelligence performance in schizophrenia did not differ with respect to diagnostic subtypes and longitudinal courses. Conclusions The current study failed to show diagnostic usefulness of WAIS‐R in discriminating schizophrenia and other psychoses. A diagnosis of schizophrenia does not significantly impact intellectual deficits in psychotic disorders. 相似文献
995.
V T Ivashkin Iu V Grigor'ev A I Sinopal'nikov N V Korneev D N Levitski? E A KazakovaIGVirs 《Kardiologiia》1991,31(8):59-61
The clinical effects of Tenoric, a long-acting combined drug (atenolol and chlorthalidone in a tablet), were studied in 31 patients with Stages I and II hypertensive disease, by using echocardiography, daily automatic blood pressure monitoring, bicycle ergometry, measurements of plasma renin and aldosterone. The drug was found to be highly clinically effective in labile and sustained hypertension. When given once or twice a day, it makes it possible to reliably monitor blood pressure, improve hemodynamic parameters, as reflected by lower cardiac output and decreased peripheral vascular resistance, reduce the estimated mass of the left myocardium, alleviate a pressor response to exercise and enhance its tolerance, lower plasma renin levels. The side effects of the drug are minimal and include moderate bradycardia. Peripheral vasospasm and systemic weakness were observed in single cases. There were no atherogenic changes in lipid spectrum and disturbed glucose and uric acid metabolism during the drug therapy. 相似文献
996.
L R Kelland P Mistry G Abel F Freidlos S Y Loh J J Roberts K R Harrap 《Cancer research》1992,52(7):1710-1716
Clinically, human testicular nonseminomatous germ cell tumors exhibit remarkable sensitivity to platinum-based chemotherapy. To define better the mechanistic basis for this unusual sensitivity, the biochemical determinants of platinum-induced cytotoxicity have been investigated in a human testicular tumor cell line (GCT27) established from a previously untreated patient and in an in vitro derived 5.6-fold cisplatin-resistant stable variant (GCT27cisR). Compared to 12 ovarian and 5 cervical human tumor cell lines, the parent GCT27 line was among the most sensitive to the cytotoxic effects of both cisplatin (dosage producing 50% inhibition, 0.2 microM) and carboplatin (dosage producing 50% inhibition, 2.9 microM), thus reflecting clinical data. A 4-day exposure sulforhodamine B-staining assay was used to determine that GCT27cisR was cross-resistant to carboplatin and iproplatin and the classical bifunctional alkylating agents melphalan and chlorambucil. Partial cross-resistance was observed to tetraplatin, methotrexate, and mitomycin C. No cross-resistance was observed to Adriamycin, etoposide, vinblastine, bleomycin, 1-beta-D-arabinofuranosylcytosine, and 5-fluorouracil. Intracellular cisplatin accumulation across the dose range 2.5-100 microM (for 2 h) was 1.6 +/- 0.39-fold (mean +/- SD) greater for the parent line. There was no significant difference in glutathione levels between the two lines. The acquired resistance line was 1.9-fold more resistant than the parent line to the cytotoxic effects of cadmium chloride. There was no significant difference between the two lines, however, in the total amounts of platinum bound to DNA after cisplatin exposure (25, 50, or 100 microM for 2 h). The removal of total platinum adducts from DNA was significantly faster for GCT27cisR compared to the parent line (half-times of removal, 32 and 67 h, respectively). These data suggest that the abnormal sensitivity of the parent testicular tumor cell line to platinum-containing anticancer drugs may be due predominantly to an inherent defect in the ability of these cells to remove platinum from their DNA. This defect is apparently lost in the acquired resistance counterpart. Reduced intracellular accumulation and increased cytoplasmic concentrations of metallothionein may also contribute, in part, to the acquisition of cisplatin resistance in this model. 相似文献
997.
Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. 总被引:3,自引:0,他引:3
A F Badawi M H Mostafa T Aboul-Azm N Y Haboubi P J O'Connor D P Cooper 《Carcinogenesis》1992,13(5):877-881
Radioimmunoassays (RIAs) have been used to detect the promutagenic lesion O6-methyldeoxyguanosine (O6-MedG) in DNA isolated from the bladder tissues of Egyptian patients presenting with bladder carcinoma and concomitant schistosomiasis (bilharziasis), a parasitic disease known to be associated with the presence of N-nitrosamines in the urine. Alkylation damage was present in the DNA of the majority of the samples (44/46, 96%); 38 samples were of tumour tissue and 8 from uninvolved bladder mucosa. Levels of O6-MedG ranged from undetectable (ND; i.e. less than 0.01 mumol O6-MedG/mol dG) to 0.485 mumol/mol dG with an overall mean of 0.134 +/- 0.10 mumol/mol dG, including the two samples that were below the limit of detection. In contrast, methylation damage was detected in only 4/12 (33%) of the DNA samples from normal bladder tissue of European origin. In these samples levels of O6-MedG ranged from ND to 0.225 mumol/mol dG with an overall mean of 0.046 +/- 0.082 mumol O6-MedG/mol dG. These results confirm that alkylation events can be detected in the DNA of schistosome-infected human bladder tissue. The methylation of uninvolved and tumour tissue DNA to similar extents suggests that the alkylating intermediate may have been present in the urine. These results indicate the need for further investigation to determine whether relationships exist between levels of DNA damage and the prevalence of schistosome infection and/or the extent and type of bacterial infection that frequently accompanies this disease. 相似文献
998.
M Higashigawa Y Komada N Washio H Kuwabara H Hori M Ido M Sakurai 《Leukemia research》1992,16(10):1049-1054
In vitro preincubation with recombinant granulocyte colony-stimulating factor(rhG-CSF, 100 ng/ml) enhanced the cytotoxicity of 1-beta-D-arabinofuranosylcytosine(Ara-C) in leukemic cells resistant to Ara-C from a patient with biphenotypic leukemia. Treatment of the cells with rhG-CSF resulted in a 17-fold increase in DNA synthesis, 4.6-fold increase in percentage of S-phase, and a two-fold increase in Ara-CTP formation. Maximal effect was observed at 72 h of incubation. Combination chemotherapy with rhG-CSF and Ara-C to the patient showed remarkable cytoreduction. These results indicate that recruitment of resistant leukemic cells in cell kinetic quiescence is inducible by rhG-CSF and that it is possible enhancement of the cytotoxicity to cell cycle-specific drugs such as Ara-C. 相似文献
999.
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force 总被引:2,自引:0,他引:2
R. Soffietti P. Cornu J. Y. Delattre R. Grant F. Graus W. Grisold J. Heimans J. Hildebrand P. Hoskin M. Kalljo P. Krauseneck C. Marosi T. Siegal C. Vecht 《European journal of neurology》2006,13(7):674-681
The objectives have been to establish evidence-based guidelines and identify controversies regarding the management of patients with brain metastases. The collection of scientific data was obtained by consulting the Cochrane Library, bibliographic databases, overview papers and previous guidelines from scientific societies and organizations. A tissue diagnosis is necessary when the primary tumor is unknown or the aspect on computed tomography/magnetic resonance imaging is atypical. Dexamethasone is the corticosteroid of choice for cerebral edema. Anticonvulsants should not be prescribed prophylactically. Surgery should be considered in patients with up to three brain metastases, being effective in prolonging survival when the systemic disease is absent/controlled and the performance status is high. Stereotactic radiosurgery should be considered in patients with metastases of 3–3.5 cm of maximum diameter. Whole-brain radiotherapy (WBRT) after surgery or radiosurgery is debated: in case of absent/controlled systemic cancer and Karnofsky Performance score of 70 or more, one can either withhold initial WBRT or deliver early WBRT with conventional fractionation to avoid late neurotoxicity. WBRT alone is the treatment of choice for patients with single or multiple brain metastases not amenable to surgery or radiosurgery. Chemotherapy may be the initial treatment for patients with brain metastases from chemosensitive tumors. 相似文献
1000.
The current study investigates the effect of megestrol acetate, a synthetic progestin, on the activity of interleukin-1. Murine thymocytes were suspended in vitro and stimulated with varying concentrations of interleukin-1. [3H]Thymidine uptake was observed as an index of thymocyte proliferation. A dose-dependent increase in [3H]thymidine uptake was observed with increasing concentrations of interleukin-1. When megestrol acetate was added to the solution, a marked suppressive effect was observed. Higher doses of megestrol acetate had a greater suppressive effect on thymocyte proliferation. Additional investigation is required to further delineate the potential systemic effects of megestrol acetate. 相似文献